Phosphoric Acid

Phosphoric Acid

SCHEMBL3390206

CC(O)C(NC(=O)CCCCCCS)C(=O)O.O=P(O)(O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.40
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
EPHX2 P34913 2/20 0.38
HDAC3 O15379 5/20 0.38
HDAC1 Q13547 5/20 0.38
HDAC2 Q92769 5/20 0.38
HDAC10 Q969S8 5/20 0.38
HDAC11 Q96DB2 5/20 0.38
HDAC8 Q9BY41 5/20 0.38
HDAC6 Q9UBN7 5/20 0.38
HDAC4 P56524 4/20 0.38
HDAC7 Q8WUI4 4/20 0.38
HDAC9 Q9UKV0 4/20 0.38
HDAC5 Q9UQL6 4/20 0.38
MME P08473 1/20 0.37
NOD1 Q9Y239 1/20 0.36
PLA2G2A P14555 1/20 0.36
PLA2G5 P39877 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL17821202 1.00 FAAH (0.40) FAAHMEN1MAPK1KMT2AEPHX2
Phosphoric Acid SCHEMBL17821199 1.00 FAAH (0.40) FAAHMEN1MAPK1KMT2AEPHX2
SCHEMBL15969793 0.94 FAAH (0.44) FAAHMEN1MAPK1KMT2AEPHX2
SCHEMBL29165688 0.94 FAAH (0.44) FAAHMEN1MAPK1KMT2AEPHX2
Phosphoric Acid SCHEMBL2441857 0.87 FAAH (0.56) FAAHMEN1MAPK1KMT2ANOD1
SCHEMBL1512990 0.82 PIN1 (0.40) FAAHMEN1MAPK1KMT2AEPHX2
SCHEMBL16093888 0.82 PIN1 (0.40) FAAHMEN1MAPK1KMT2AEPHX2
SCHEMBL148909 0.82 PIN1 (0.40) FAAHMEN1MAPK1KMT2AEPHX2
SCHEMBL17821203 0.82 PIN1 (0.40) FAAHMEN1MAPK1KMT2AEPHX2
SCHEMBL17821198 0.82 PIN1 (0.40) FAAHMEN1MAPK1KMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382589-A1 SYNTHETIC OPERONS FOR THE PRODUCTION OF 2-MERCAPTOETHANE SULFONATE (COENZYME M) AND METHODS OF USING THE SAME UNIV NEBRASKA (US) 2025-12-18 US disclosed
US-10729132-B2 Xylophage control using antimethanogenic reagents Environmetal Intellectual Property, Inc. (US) 2020-08-04 US disclosed
US-10689673-B2 Bioconversion process for producing nylon-7, nylon-7,7 and polyesters INVISTA NORTH AMERICA S.A.R.L. (US) 2020-06-23 US disclosed
US-10577634-B2 Bioconversion process for producing nylon-7, nylon-7,7 and polyesters INVISTA NORTH AMERICA S.A.R.L. (US) 2020-03-03 US disclosed
US-10219518-B2 Inhibition of methanogenesis to control wood boring insects and pestilence Environmental Intellectual Property, Inc. (US) 2019-03-05 US disclosed
US-20180213777-A1 XYLOPHAGE CONTROL USING ANTIMETHANOGENIC REAGENTS Environmental Intellectual Property, Inc 2018-08-02 US disclosed
US-20180179499-A1 BIOBASED PRODUCTION OF FUNCTIONALIZED ALPHA-SUBSTITUTED ACRYLATES AND C4-DICARBOXYLATES LCY BIOSCIENCES INC. (CA) 2018-06-28 US disclosed
EP-3303375-A1 BIOBASED PRODUCTION OF FUNCTIONALIZED ALPHA-SUBSTITUTED ACRYLATES AND C4-DICARBOXYLATES BioAmber Inc. (US) 2018-04-11 EP disclosed
US-20170298396-A1 BIOCONVERSION PROCESS FOR PRODUCING NYLON-7, NYLON-7,7 AND POLYESTERS INV NYLON CHEMICALS AMERICAS, LLC 2017-10-19 US disclosed
US-9650653-B2 Bioconversion process for producing nylon-7, nylon-7,7 and polyesters INVISTA NORTH AMERICA S.A.R.L. (US) 2017-05-16 US disclosed
US-8778642-B2 Biological synthesis of difunctional alkanes from carbohydrate feedstocks CELEXION, LLC (US) 2014-07-15 US disclosed
EP-2726627-A2 BIOCONVERSION PROCESS FOR PRODUCING NYLON-7, NYLON-7,7 AND POLYESTERS Invista Technologies S.à.r.l. (CH) 2014-05-07 EP disclosed
US-20130217612-A1 COMPLETE GENOME SEQUENCE OF THE METHANOGEN METHANOBREVIBACTER RUMINANTIUM ALTERMANN ERIC HEINZ (NZ) 2013-08-22 US disclosed
WO-2013096898-A2 BIOCONVERSION PROCESS FOR PRODUCING NYLON-7, NYLON-7,7 AND POLYESTERS INVISTA NORTH AMERICA S.A.R.L. (US) 2013-06-27 WO disclosed
WO-2013003744-A2 BIOCONVERSION PROCESS FOR PRODUCING NYLON-7, NYLON-7,7 AND POLYESTERS INVISTA TECHONOLOGIES S.A R.L (CH) 2013-01-03 WO disclosed
US-20120258504-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL ALKANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC (US) 2012-10-11 US disclosed
EP-2470660-A1 COMPLETE GENOME SEQUENCE OF THE METHANOGEN METHANOBREVIBACTER RUMINANTIUM Pastoral Greenhouse Gas Research Ltd (NZ) 2012-07-04 EP disclosed
US-20120164702-A1 BIOLOGICAL SYNTHESIS OF DIFUNCTIONAL ALKANES FROM CARBOHYDRATE FEEDSTOCKS CELEXION, LLC (US) 2012-06-28 US disclosed
US-8192976-B2 Biological synthesis of difunctional alkanes from carbohydrate feedstocks CELEXION, LLC (US) 2012-06-05 US disclosed
US-20100151536-A1 Biological Synthesis of Difunctional Alkanes from Carbohydrate Feedstocks CELEXION, LLC 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179499-A1 BIOBASED PRODUCTION OF FUNCTIONALIZED ALPHA-SUBSTITUTED ACRYLATES AND C4-DICARBOXYLATES COASY, ADSL, ALAD FAAH 1300/4885MEN1 965/4885MAPK1 3810/4885
US-20180213777-A1 XYLOPHAGE CONTROL USING ANTIMETHANOGENIC REAGENTS OAT, HMGCR, GYS2 FAAH 1364/4885MEN1 3444/4885MAPK1 1712/4885
US-10729132-B2 Xylophage control using antimethanogenic reagents OAT, HMGCR, GYS2 FAAH 1364/4885MEN1 3444/4885MAPK1 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.